Mark W Hahn sold $2.7M of Verona Pharma (VRNA)

Executed Aug 1 2025, disclosed Aug 5 2025, 4 days later.

Value, as filed

$2.7M

208,912 sh × $13.14

Executed

Aug 1 2025

the trade date, as filed

Disclosed

Aug 5 2025

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

MH Mark W Hahn Chief Financial Officer profile →

Mark W Hahn (Chief Financial Officer) filed 10 Form 4 reports in the past 24 months (0 purchases, 10 sales), most often in VRNA. The largest single filing was $5.3M of VRNA (587,008 sh across 3 lots, as filed), executed May 1 2025.

The name

VRNA VRNA VRNA · 40 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Mark W Hahn in VRNA

VRNASALE Verona Pharma plc $4.6M
400,000 sh × $11.40
Exec Jun 11 2025
Filed Jun 13 2025 · 5:30 PM ET VRNASALE Verona Pharma plc $3.7M
400,000 sh across 3 lots
Exec May 27 2025
Filed May 29 2025 · 5:30 PM ET VRNASALE Verona Pharma plc $5.3M
587,008 sh across 3 lots
Exec May 1 2025
Filed May 5 2025 · 5:30 PM ET VRNASALE Verona Pharma plc $811K
90,360 sh × $8.98
Exec Apr 29 2025
Filed May 1 2025 · 5:30 PM ET VRNASALE Verona Pharma plc $4.4M
881,960 sh across 3 lots
Exec Dec 4 2024
Filed Dec 6 2024 · 5:30 PM ET VRNASALE Verona Pharma plc $495K
98,704 sh × $5.01
Exec Nov 29 2024
Filed Dec 2 2024 · 5:30 PM ET VRNASALE Verona Pharma plc $569K
129,672 sh across 2 lots
Exec Nov 1 2024
Filed Nov 5 2024 · 5:30 PM ET VRNASALE Verona Pharma plc $619K
141,360 sh × $4.38
Exec Oct 24 2024
Filed Oct 25 2024 · 5:30 PM ET